Literature DB >> 11005212

The tyrosine kinase inhibitor tyrphostin AG 126 reduced the development of colitis in the rat.

S Cuzzocrea1, M C McDonald, E Mazzon, H Mota-Filipe, V Lepore, A Ciccolo, M L Terranova, D Britti, A P Caputi, C Thiemermann.   

Abstract

Inflammatory bowel disease is characterized by oxidative and nitrosative stress, leukocyte infiltration, up-regulation of the expression of intercellular adhesion molecule-1 (ICAM-1), and up-regulation of P-selectin in the colon. Here we investigate the effects of the tyrosine kinase inhibitor, Tyrphostin AG 126, in rats subjected to experimental colitis. Colitis was induced in rats by intracolonic instillation of dinitrobenzene sulfonic acid (DNBS). Rats experienced hemorrhagic diarrhea and weight loss. Four days after administration of DNBS, the mucosa of the colon exhibited large areas of necrosis. Neutrophil infiltration (determined by histology as well as an increase in myeloperoxidase activity in the mucosa) was associated with up-regulation of ICAM-1 and P-selectin, as well as high tissue levels of malondialdehyde. Immunohistochemistry for nitrotyrosine and poly(ADP-ribose) polymerase showed an intense staining in the inflamed colon. Staining with an anti-COX-2 antibody of sections of colon obtained from DNBS-treated rats showed a diffuse staining of the inflamed tissue. Furthermore, expression of inducible nitric oxide synthase was found mainly in macrophages located within the inflamed colon of DNBS-treated rats. Tyrphostin AG 126 (5 mg/kg daily ip) significantly reduced the degree of hemorrhagic diarrhea and weight loss caused by administration of DNBS. Tyrphostin AG 126 also caused a substantial reduction of (1) the phosphorylation of tyrosine residues of proteins (immunoblots of inflamed colon), (2) the degree of colonic injury, (3) the rise in myeloperoxidase activity (mucosa), (4) the increase in the tissue levels of malondialdehyde, (5) the increase in staining (immunohistochemistry) for nitrotyrosine and poly(ADP-ribose) polymerase, as well as (6) the up-regulation of ICAM-1 and P-selectin caused by DNBS in the colon. Thus, we provide the first evidence that the tyrosine kinase inhibitor Tyrphostin AG126 reduces the degree of colitis caused by DNBS.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11005212     DOI: 10.1038/labinvest.3780151

Source DB:  PubMed          Journal:  Lab Invest        ISSN: 0023-6837            Impact factor:   5.662


  3 in total

1.  Tyrphostin AG 126 reduces intestinal ischemia-reperfusion injury in the rat.

Authors:  Stefania Marzocco; Emanuela Mazzon; Aldo Pinto; Giuseppina Autore; Salvatore Cuzzocrea
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2006-02-17       Impact factor: 3.000

2.  Nilotinib-mediated mucosal healing in a rat model of colitis.

Authors:  Pinar Ataca; Mujde Soyturk; Meral Karaman; Mehtat Unlu; Ozgul Sagol; Gozde Dervis Hakim; Osman Yilmaz
Journal:  World J Gastroenterol       Date:  2013-10-07       Impact factor: 5.742

3.  Mucosal healing effect of nilotinib in indomethacin-induced enterocolitis: A rat model.

Authors:  Gozde Dervis Hakim; Mujde Soyturk; Mehtat Unlu; Pinar Ataca; Meral Karaman; Ozgul Sagol; Elif Borekci; Osman Yilmaz
Journal:  World J Gastroenterol       Date:  2015-11-28       Impact factor: 5.742

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.